Show simple item record

dc.contributor.authorJabbari, M
dc.contributor.authorKheirouri, S
dc.contributor.authorAlizadeh, M
dc.date.accessioned2018-08-26T08:51:22Z
dc.date.available2018-08-26T08:51:22Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53366
dc.description.abstractObjective We aimed to investigate the association between serum levels of ghrelin and brain-derived neurotrophic factor (BDNF) with MetS and its components in premenopausal women. Methods 43 patients with MetS and 43 healthy controls participated in this study. Participants' body mass index (BMI), waist circumference (WC), systolic and diastolic blood pressure (SBP and DBP) were measured. Serum levels of total cholesterol (TC), triglyceride (TG), low and high density lipoprotein cholesterol (LDL-C and HDL-C), fasting blood sugar (FBS), insulin, BDNF and ghrelin determined. Homeostasis model assessment insulin resistance index (HOMA-IR) was also calculated. Results Participants in MetS group had higher waist-to-hip ratios, elevated SBP and DBP, and higher serum levels of TG, FBS and insulin when compared with the control group. Serum ghrelin and BDNF levels were significantly lower in participants with MetS than in the healthier control subjects. There was a strong, positive correlation between serum ghrelin and BDNF levels. Both proteins negatively correlated with TG, FBS, HOMA-IR and positively with HDL-C. Furthermore, serum BDNF levels negatively associated with insulin levels. Conclusions The findings indicate that variations occur in the circulating level of ghrelin and BDNF proteins in MetS patients. A strong correlation between serum ghrelin and BDNF suggests that production, release or practice of these 2 proteins might be related mechanically. é American Society for Clinical Pathology 2018. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofLab Medicine
dc.subjectbrain derived neurotrophic factor
dc.subjectghrelin
dc.subjectglucose
dc.subjecthigh density lipoprotein cholesterol
dc.subjectinsulin
dc.subjectlow density lipoprotein cholesterol
dc.subjecttriacylglycerol
dc.subjectbrain derived neurotrophic factor
dc.subjectbrain-derived neurotrophic factor, human
dc.subjectghrelin
dc.subjectadult
dc.subjectArticle
dc.subjectbody mass
dc.subjectcholesterol blood level
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectdiastolic blood pressure
dc.subjectdisease association
dc.subjectfemale
dc.subjectglucose blood level
dc.subjecthomeostasis model assessment
dc.subjecthormone blood level
dc.subjecthuman
dc.subjectinsulin blood level
dc.subjectmetabolic syndrome X
dc.subjectpremenopause
dc.subjectprotein blood level
dc.subjectsystolic blood pressure
dc.subjecttriacylglycerol blood level
dc.subjectwaist circumference
dc.subjectwaist hip ratio
dc.subjectblood
dc.subjectcase control study
dc.subjectmetabolic syndrome X
dc.subjectmiddle aged
dc.subjectpremenopause
dc.subjectAdult
dc.subjectBrain-Derived Neurotrophic Factor
dc.subjectCase-Control Studies
dc.subjectFemale
dc.subjectGhrelin
dc.subjectHumans
dc.subjectMetabolic Syndrome
dc.subjectMiddle Aged
dc.subjectPremenopause
dc.titleDecreased Serum Levels of Ghrelin and Brain-Derived Neurotrophic Factor in Premenopausal Women with Metabolic Syndrome
dc.typeArticle
dc.citation.volume49
dc.citation.issue2
dc.citation.spage140
dc.citation.epage146
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1093/labmed/lmx087


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record